SMR

NuScale Power Corporation

39
Fundamentals12/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential40/ 100

SMR offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

TAC

TransAlta Corporation

51
Fundamentals44/ 100
Valuation50/ 100
Upside potential56/ 100
Risk potential21/ 100

TAC has the edge over SMR overall, supported by stronger fundamentals and lower modeled downside.

SMR Fundamentals

MetricStatus
Weak
Weak
Weak
Unavailable

SMR's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.

TAC Fundamentals

MetricStatus
Under pressure
Stable
Strong
Weak

TAC's cash flow is currently strong, and its profitability is stable, but its revenue and balance sheet are under pressure.

SMR PE Valuation

SMR has no meaningful PE right now: it lost money over the past year.

TAC PE Valuation

TAC has no meaningful PE right now: it lost money over the past year.

SMR Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
--
Limited
High

Analysts expect SMR's losses to shrink, with revenue growing.

TAC Forward outlook

MetricOutlook
--
Strong growth
Stable
Strongly improving
Limited
High

Analysts expect TAC's earnings to grow and its profitability to improve, with its revenue holding steady.

SMR Risk to reward

ScenarioChangePrice
Upside+70%$8.20
Downside-40%$2.88

Calculated from the latest close: $4.82 on Nov 12.

SMR has a better modeled risk to reward balance than TAC, with more potential upside relative to its potential downside.

TAC Risk to reward

ScenarioChangePrice
Upside+27%$16.84
Downside-21%$10.47

Calculated from the latest close: $13.28 on Nov 12.

TAC trails SMR on modeled risk to reward, with less potential upside relative to its potential downside.

SMR Earnings Per Share

Q4 2023: $-0.80Q1 2024: $-0.85Q2 2024: $-1.03Q3 2024: $-0.95Q4 2024: $-1.47Q1 2025: $-1.37Q2 2025: $-1.19Q3 2025: $-2.86Q4 2025: $-2.43Q1 2026: $-2.46Q2 2026: $-2.46Q3 2026: $-0.72
Q4 2023: $-0.80Q1 2024: $-0.85Q2 2024: $-1.03Q3 2024: $-0.95Q4 2024: $-1.47Q1 2025: $-1.37Q2 2025: $-1.19Q3 2025: $-2.86Q4 2025: $-2.43Q1 2026: $-2.46Q2 2026: $-2.46Q3 2026: $-0.72
QuarterTTM EPSYoY
Q3 2026-$0.72+$2.14
Q2 2026-$2.46-$1.27
Q1 2026-$2.46-$1.09
Q4 2025-$2.43-$0.96
Q3 2025-$2.86-$1.91
Q2 2025-$1.19-$0.16
Q1 2025-$1.37-$0.52
Q4 2024-$1.47-$0.67

SMR is still losing money, but far less than before: $0.72 per share over the past year, against $2.86 at its worst in late 2025.

TAC Earnings Per Share

Q3 2023: $1.71Q4 2023: $1.79Q1 2024: $1.53Q2 2024: $1.49Q3 2024: $0.41Q4 2024: $0.39Q1 2025: $-0.01Q2 2025: $-0.40Q3 2025: $-0.46Q4 2025: $-0.45Q1 2026: $-0.52Q2 2026: $-0.17
Q3 2023: $1.71Q4 2023: $1.79Q1 2024: $1.53Q2 2024: $1.49Q3 2024: $0.41Q4 2024: $0.39Q1 2025: $-0.01Q2 2025: $-0.40Q3 2025: $-0.46Q4 2025: $-0.45Q1 2026: $-0.52Q2 2026: $-0.17
QuarterTTM EPSYoY
Q2 2026-$0.17+$0.23
Q1 2026-$0.52-$0.51
Q4 2025-$0.45-215%
Q3 2025-$0.46-212%
Q2 2025-$0.40-127%
Q1 2025-$0.01-101%
Q4 2024$0.39-78%
Q3 2024$0.41-76%

TAC is still losing money, but far less than before: $0.17 per share over the past year, against $1.63 at its worst in late 2021.

SMR Quarterly Revenue

Q4 2023: $5MQ1 2024: $1MQ2 2024: $967,000Q3 2024: $475,000Q4 2024: $34MQ1 2025: $13MQ2 2025: $8MQ3 2025: $8MQ4 2025: $2MQ1 2026: $565,000Q2 2026: $75,000Q3 2026: $281,000
Q4 2023: $5MQ1 2024: $1MQ2 2024: $967,000Q3 2024: $475,000Q4 2024: $34MQ1 2025: $13MQ2 2025: $8MQ3 2025: $8MQ4 2025: $2MQ1 2026: $565,000Q2 2026: $75,000Q3 2026: $281,000
QuarterRevenueYoY
Q3 2026$281K-97%
Q2 2026$75K-99%
Q1 2026$565K-96%
Q4 2025$1.8M-95%
Q3 2025$8.2M+1635%
Q2 2025$8.1M+733%
Q1 2025$13.4M+870%
Q4 2024$34.2M+651%

SMR has the edge over TAC on sales, with more consistent year-over-year improvement.

TAC Quarterly Revenue

Q3 2023: $715MQ4 2023: $439MQ1 2024: $666MQ2 2024: $409MQ3 2024: $449MQ4 2024: $477MQ1 2025: $533MQ2 2025: $304MQ3 2025: $432MQ4 2025: $421MQ1 2026: $398MQ2 2026: $342M
Q3 2023: $715MQ4 2023: $439MQ1 2024: $666MQ2 2024: $409MQ3 2024: $449MQ4 2024: $477MQ1 2025: $533MQ2 2025: $304MQ3 2025: $432MQ4 2025: $421MQ1 2026: $398MQ2 2026: $342M
QuarterRevenueYoY
Q2 2026$342.4M+12%
Q1 2026$398.2M-25%
Q4 2025$420.8M-12%
Q3 2025$432.4M-3.6%
Q2 2025$304.4M-26%
Q1 2025$532.9M-20%
Q4 2024$476.7M+8.7%
Q3 2024$448.5M-37%

TAC's revenue is recovering but still below its 2023 peak: $342M last quarter, up 12% from the same quarter a year ago.

SMR Free Cash Flow

Q4 2023: −$73MQ1 2024: −$33MQ2 2024: −$36MQ3 2024: −$13MQ4 2024: −$26MQ1 2025: −$23MQ2 2025: −$33MQ3 2025: --Q4 2025: −$204MQ1 2026: −$316MQ2 2026: −$59MQ3 2026: −$29M
Q4 2023: −$73MQ1 2024: −$33MQ2 2024: −$36MQ3 2024: −$13MQ4 2024: −$26MQ1 2025: −$23MQ2 2025: −$33MQ3 2025: --Q4 2025: −$204MQ1 2026: −$316MQ2 2026: −$59MQ3 2026: −$29M
QuarterFree cash flowYoY
Q2 2026-$58.6M-$25.3M
Q1 2026-$316.2M-$293.3M
Q4 2025-$204.1M-$177.6M
Q2 2025-$33.3M+$2.7M
Q1 2025-$22.9M+$10.6M
Q4 2024-$26.5M+$46.8M
Q3 2024-$12.7M+$15M
Q2 2024-$36M+$4.5M

TAC has the stronger cash trend. Its trailing FCF is up 36% versus its history, compared with SMR at down 161%.

TAC Free Cash Flow

Q3 2023: $361MQ4 2023: $51MQ1 2024: $123MQ2 2024: $33MQ3 2024: $107MQ4 2024: $71MQ1 2025: −$19MQ2 2025: $56MQ3 2025: $138MQ4 2025: $103MQ1 2026: $66MQ2 2026: $12M
Q3 2023: $361MQ4 2023: $51MQ1 2024: $123MQ2 2024: $33MQ3 2024: $107MQ4 2024: $71MQ1 2025: −$19MQ2 2025: $56MQ3 2025: $138MQ4 2025: $103MQ1 2026: $66MQ2 2026: $12M
QuarterFree cash flowYoY
Q2 2026$12M-78%
Q1 2026$65.6M+$84.5M
Q4 2025$103.3M+45%
Q3 2025$137.8M+29%
Q2 2025$55.5M+68%
Q1 2025-$19M-115%
Q4 2024$71M+40%
Q3 2024$106.9M-70%

TAC still generates free cash flow, though less than at its 2023 peak: $319M over the past year.

SMR Total Shares

Q4 2023: 73MQ1 2024: 80MQ2 2024: 90MQ3 2024: 95MQ4 2024: 93MQ1 2025: 128MQ2 2025: 133MQ3 2025: 148MQ4 2025: 164MQ1 2026: 320MQ2 2026: 365MQ3 2026: 410M
Q4 2023: 73MQ1 2024: 80MQ2 2024: 90MQ3 2024: 95MQ4 2024: 93MQ1 2025: 128MQ2 2025: 133MQ3 2025: 148MQ4 2025: 164MQ1 2026: 320MQ2 2026: 365MQ3 2026: 410M
PeriodChange %Net change
Quarterly+13%+45.9M shares
1 year+178%+263M shares
3 years+448%+336M shares

SMR has 410M diluted shares, up 178% from a year ago.

TAC Total Shares

Q3 2023: 263MQ4 2023: 308MQ1 2024: 308MQ2 2024: 303MQ3 2024: 296MQ4 2024: 296MQ1 2025: 298MQ2 2025: 298MQ3 2025: 310MQ4 2025: 297MQ1 2026: 297MQ2 2026: 302M
Q3 2023: 263MQ4 2023: 308MQ1 2024: 308MQ2 2024: 303MQ3 2024: 296MQ4 2024: 296MQ1 2025: 298MQ2 2025: 298MQ3 2025: 310MQ4 2025: 297MQ1 2026: 297MQ2 2026: 302M
PeriodChange %Net change
Quarterly+1.7%+5M shares
1 year+1.3%+4M shares
3 years+14%+38M shares
5 years+12%+32M shares
Available history+7.1%+20M shares

TAC has the edge over SMR on shareholder dilution, with a more favorable share count trend.

SMR Net Leverage

SMR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

TAC Net Leverage

Q3 2023: 1.7xQ4 2023: 2.0xQ1 2024: 2.5xQ2 2024: 2.5xQ3 2024: 3.5xQ4 2024: 3.8xQ1 2025: 4.8xQ2 2025: 5.7xQ3 2025: 5.8xQ4 2025: 5.7xQ1 2026: 6.1xQ2 2026: 4.9x
Q3 2023: 1.7xQ4 2023: 2.0xQ1 2024: 2.5xQ2 2024: 2.5xQ3 2024: 3.5xQ4 2024: 3.8xQ1 2025: 4.8xQ2 2025: 5.7xQ3 2025: 5.8xQ4 2025: 5.7xQ1 2026: 6.1xQ2 2026: 4.9x
QuarterNet LeverageStatus
Q2 20264.9xHigh
Q1 20266.1xHigh
Q4 20255.7xHigh
Q3 20255.8xHigh
Q2 20255.7xHigh
Q1 20254.8xHigh
Q4 20243.8xElevated
Q3 20243.5xElevated

TAC's net debt is about 4.9 years of its operating earnings (EBITDA), down from 5.7 years a year ago.

SMR Weekly Momentum

MetricValueStatus
RSI29.5Oversold
Stochastic8.6Oversold

SMR's weekly RSI is 30 (oversold) and its Stochastic is 9 (oversold).

TAC Weekly Momentum

MetricValueStatus
RSI53.9Neutral
Stochastic65.9Neutral

TAC's weekly RSI is 54 (neutral) and its Stochastic is 66 (neutral).

SMR PE vs Utilities Sector

SMR has no meaningful PE right now: it lost money over the past year.

TAC PE vs Utilities Sector

MetricTACSector medianRelative
PEN/A20x—

TAC has no meaningful PE right now: it lost money over the past year.

SMR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$6.2623% below
20 week MA$7.8839% below
50 week MA$11.458% below
100 week MA$20.276% below
200 week MA$14.467% below

SMR is in a downtrend: it's below all five of its weekly moving averages, and 67% below its 200-week average.

TAC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.74.8% above
20 week MA$12.74.4% above
50 week MA$12.92.6% above
100 week MA$12.56.6% above
200 week MA$10.526% above

TAC has the edge over SMR on trend strength, trading above more of its moving averages.

SMR Yearly ROI

YearStart priceEnd priceROI
2020$10.1$10.3+1.2%
2021$10.3$10.1-1.9%
2022$10.1$10.1+0.5%
2023$10.1$3.29-67%
2024$3.29$19.5+493%
2025$19.5$14.9-24%
2026 YTD$14.9$4.82-68%

SMR's yearly returns have swung widely, from +493% in 2024 to −67% in 2023. It's down 68% so far in 2026.

TAC Yearly ROI

YearStart priceEnd priceROI
2020$7.03$7.37+4.8%
2021$7.37$11.1+51%
2022$11.1$8.78-21%
2023$8.78$8.31-5.4%
2024$8.31$14.2+71%
2025$14.2$12.8-9.8%
2026 YTD$12.8$13.3+3.4%

TAC has the edge over SMR on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key